Thapsigargin affinity purification of intracellular P2A-type Ca2+ ATPases

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 1118-1127

  Vandecaetsbeek, Ilse ^a   Christensen, Søren Brøgger ^b   Liu, Huizhen ^b   Van Veldhoven, Paul P ^a   Waelkens, Etienne ^a   Eggermont, Jan ^a   Raeymaekers, Luc ^a   Møller, Jesper V ^c   Nissen, Poul ^c   Wuytack, Frank ^a   Vangheluwe, Peter ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Ca2+ pumps; Chromatography; Endoplasmic reticulum; Golgi; SERCA2b; SPCA1a

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); DETERGENT; RECOMBINANT HSERCA2B; RECOMBINANT HSPCA1A; RECOMBINANT PROTEIN; THAPSIGARGIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL DIVISION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG PROTEIN BINDING; ELUTION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN PURIFICATION; SARCOPLASMIC RETICULUM; YEAST;

BINDING SITES; CALCIUM-TRANSPORTING ATPASES; CHROMATOGRAPHY, AFFINITY; HUMANS; INTRACELLULAR SPACE; MUTANT PROTEINS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THAPSIGARGIN;

EID: 79955665186     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.12.020     Document Type: Article

References (58)

1. Shinoda T., Ogawa H., Cornelius F., Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 2009, 459:446-450.
2. Toyoshima C., Nakasako M., Nomura H., Ogawa H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 2000, 405:647-655.
3. 2+-ATPase pumps ions across the sarcoplasmic reticulum membrane. Biochim. Biophys. Acta 2009, 1793:941-946.
4. 2+-transport ATPases. Chem. Rev. 2009, 109:4733-4759.
5. 2+-ATPase pump. Curr. Opin. Struct. Biol. 2005, 15:387-393.
6. Berridge M.J. Calcium signal transduction and cellular control mechanisms. Biochim. Biophys. Acta 2004, 1742:3-7.
7. Albers R.W. Biochemical aspects of active transport. Annu. Rev. Biochem. 1967, 36:727-756.
8. Moller J.V., Juul B., le Maire M. Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim. Biophys. Acta 1996, 1286:1-51.
9. 2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses. J. Biol. Chem. 2003, 278:47877-47889.
10. 2+-pump. Proc. Natl. Acad. Sci. USA 2009, 106:18533-18538.
11. 2+-ATPase. Meth. Mol. Biol. 2010, 601:247-267.
12. Cardi D., Pozza A., Arnou B., Marchal E., Clausen J.D., Andersen J.P., Krishna S., Moller J.V., le Maire M., Jaxel C. Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins. J. Biol. Chem. 2010, 285:26406-26416.
13. Jidenko M., Nielsen R.C., Sorensen T.L., Moller J.V., le Maire M., Nissen P., Jaxel C. Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 2005, 102:11687-11691.
14. Pedersen B.P., Buch-Pedersen M.J., Morth J.P., Palmgren M.G., Nissen P. Crystal structure of the plasma membrane proton pump. Nature 2007, 450:1111-1114.
15. 2+-ATPase in yeast. FEBS Lett. 1994, 354:117-122.
16. Jidenko M., Lenoir G., Fuentes J.M., le Maire M., Jaxel C. Expression in yeast and purification of a membrane protein, SERCA1a, using a biotinylated acceptor domain. Protein Expr. Purif. 2006, 48:32-42.
17. Christensen S.B. Thapsigargin and thapsigarcin, two histamine liberating sesquiterpene lactones from Thapsia garganica. J. Org. Chem. 1982, 47:649-652.
18. 2+-transport ATPase by thapsigargin at subnanomolar concentrations. J. Biol. Chem. 1991, 266:13503-13506.
19. Takahashi M., Kondou Y., Toyoshima C. Interdomain communication in calcium pump as revealed in the crystal structures with transmembrane inhibitors. Proc. Natl. Acad. Sci. USA 2007, 104:5800-5805.
20. 2+-ATPase (SPCA) 1 and 2 isoenzymes by steady-state and transient kinetic analyses. J. Biol. Chem. 2006, 281:3182-3189.
21. Lee K.M., DaSilva N.A. Evaluation of the Saccharomyces cerevisiae ADH2 promoter for protein synthesis. Yeast 2005, 22:431-440.
22. Gietz R.D., Schiestl R.H. Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat. Protoc. 2007, 2:38-41.
23. Riezman H., Hase T., van Loon A.P., Grivell L.A., Suda K., Schatz G. Import of proteins into mitochondria: a 70 kilodalton outer membrane protein with a large carboxy-terminal deletion is still transported to the outer membrane. EMBO J. 1983, 2:2161-2168.
24. Volland C., Urban-Grimal D., Geraud G., Haguenauer-Tsapis R. Endocytosis and degradation of the yeast uracil permease under adverse conditions. J. Biol. Chem. 1994, 269:9833-9841.
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
26. Andrews S.P., Ball M., Wierschem F., Cleator E., Oliver S., Hogenauer K., Simic O., Antonello A., Hunger U., Smith M.D., Ley S.V. Total synthesis of five thapsigargins: guaianolide natural products exhibiting sub-nanomolar SERCA inhibition. Chemistry 2007, 13:5688-5712.
27. Ball M., Andrews S.P., Wierschem F., Cleator E., Smith M.D., Ley S.V. Total synthesis of thapsigargin, a potent SERCA pump inhibitor. Org. Lett. 2007, 9:663-666.
28. De D., Krogstad F.M., Byers L.D., Krogstad D.J. Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. J. Med. Chem. 1998, 41:4918-4926.
29. 2+-affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span. J. Mol. Cell. Cardiol. 2006, 41:308-317.
30. 2+-transport ATPase. Biochem. J. 1989, 264:765-769.
31. 2+ accumulation in the Golgi apparatus of HeLa cells assessed via RNA-mediated interference. Biochem. Biophys. Res. Commun. 2003, 306:430-436.
32. D'Hertog W., Overbergh L., Lage K., Ferreira G.B., Maris M., Gysemans C., Flamez D., Cardozo A.K., Van den Bergh G., Schoofs L., Arckens L., Moreau Y., Hansen D.A., Eizirik D.L., Waelkens E., Mathieu C. Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol. Cell. Proteomics 2007, 6:2180-2199.
33. 2+ ions. J. Biol. Chem. 2005, 280:22800-22808.
34. Sarkadi B., Enyedi A., Foldes-Papp Z., Gardos G. Molecular characterization of the in situ red cell membrane calcium pump by limited proteolysis. J. Biol. Chem. 1986, 261:9552-9557.
35. Sagara Y., Wade J.B., Inesi G. A conformational mechanism for formation of a dead-end complex by the sarcoplasmic reticulum ATPase with thapsigargin. J. Biol. Chem. 1992, 267:1286-1292.
36. 2+)-activated ATPase from sarcoplasmic reticulum. Effect of protein-protein interactions. J. Biol. Chem. 1980, 255:1912-1920.
37. 2+-pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors. J. Biol. Chem. 2006, 281:6970-6976.
38. 2+-ATPase SERCA. J. Biol. Chem. 2004, 279:17973-17979.
39. Engelender S., De Meis L. Pharmacological differentiation between intracellular calcium pump isoforms. Mol. Pharmacol. 1996, 50:1243-1252.
40. 2+-ATPase. J. Biotechnol. 2006, 124:704-716.
41. 2+ release. J. Biol. Chem. 2008, 283:14867-14882.
42. Moncoq K., Trieber C.A., Young H.S. The molecular basis for cyclopiazonic acid inhibition of the sarcoplasmic reticulum calcium-pump. J. Biol. Chem. 2007, 282:9748-9757.
43. 2+-ATPase of sarcoplasmic reticulum by affinity chromatography. J. Biol. Chem. 1984, 259:14249-14254.
44. 2+-ATPase from sarcoplasmic reticulum. Symmetry and molecular packing. Biophys. J. 1990, 57:1-14.
45. 2+-ATPase from cardiac sarcoplasmic reticulum membranes. Protein Expr. Purif. 1998, 13:191-197.
46. Toyoshima C., Nomura H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 2002, 418:605-611.
47. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
48. 2+-ATPase (SERCA) catalytic cycle. Biochemistry 2006, 45:13769-13778.
49. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 1989, 264:17816-17823.
50. 2+-stores. FEBS Lett. 1990, 274:214-216.
51. Christensen S.B., Skytte D.M., Denmeade S.R., Dionne C., Moller J.V., Nissen P., Isaacs J.T. A Trojan horse in drug development: targeting of thapsigargins towards prostate cancer cells. Anticancer Agents Med. Chem. 2009, 9:276-294.
52. Sohoel H., Jensen A.M., Moller J.V., Nissen P., Denmeade S.R., Isaacs J.T., Olsen C.E., Christensen S.B. Natural products as starting materials for development of second-generation SERCA inhibitors targeted towards prostate cancer cells. Bioorg. Med. Chem. 2006, 14:2810-2815.
53. 2+-ATPase inhibitors designed by an analysis of the binding site of thapsigargin. J. Med. Chem. 2005, 48:7005-7011.
54. Singh P., Mhaka A.M., Christensen S.B., Gray J.J., Denmeade S.R., Isaacs J.T. Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase. J. Med. Chem. 2005, 48:3005-3014.
55. Ley S.V., Antonello A., Balskus E.P., Booth D.T., Christensen S.B., Cleator E., Gold H., Hogenauer K., Hunger U., Myers R.M., Oliver S.F., Simic O., Smith M.D., Sohoel H., Woolford A.J. Synthesis of the thapsigargins. Proc. Natl. Acad. Sci. USA 2004, 101:12073-12078.
56. 2+-ATPase with thapsigargin and thapsigargin analogs. J. Biol. Chem. 2010, 285:28883-28892.
57. 2+-transport ATPase mediate resistance to thapsigargin in thapsigargin-resistant hamster cells. J. Biol. Chem. 1998, 273:3542-3546.
58. Denmeade S.R., Isaacs J.T. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Cancer Biol. Ther. 2005, 4:14-22.